Hutchison D, Hosking A, Hong E, Grando S
Antibodies (Basel). 2022; 11(3).
PMID: 36134951
PMC: 9495650.
DOI: 10.3390/antib11030055.
Ramani P, Ravikumar R, Pandiar D, Monica K, Krishnan R, Ramasubramanian A
Apoptosis. 2022; 27(5-6):322-328.
PMID: 35445279
DOI: 10.1007/s10495-022-01726-z.
Lim Y, Bohelay G, Hanakawa S, Musette P, Janela B
Front Mol Biosci. 2022; 8:808536.
PMID: 35187073
PMC: 8855930.
DOI: 10.3389/fmolb.2021.808536.
Grando S, Kawashima K, Wessler I
Int Immunopharmacol. 2020; 81:106289.
PMID: 32113128
PMC: 10612399.
DOI: 10.1016/j.intimp.2020.106289.
Sinha A, Sajda T
Front Med (Lausanne). 2018; 5:218.
PMID: 30155465
PMC: 6102394.
DOI: 10.3389/fmed.2018.00218.
Non-Desmoglein Antibodies in Patients With Pemphigus Vulgaris.
Amber K, Valdebran M, Grando S
Front Immunol. 2018; 9:1190.
PMID: 29915578
PMC: 5994403.
DOI: 10.3389/fimmu.2018.01190.
Critical Role of the Neonatal Fc Receptor (FcRn) in the Pathogenic Action of Antimitochondrial Autoantibodies Synergizing with Anti-desmoglein Autoantibodies in Pemphigus Vulgaris.
Chen Y, Chernyavsky A, Webber R, Grando S, Wang P
J Biol Chem. 2015; 290(39):23826-37.
PMID: 26260795
PMC: 4583029.
DOI: 10.1074/jbc.M115.668061.
Mechanisms of mitochondrial damage in keratinocytes by pemphigus vulgaris antibodies.
Kalantari-Dehaghi M, Chen Y, Deng W, Chernyavsky A, Marchenko S, Wang P
J Biol Chem. 2013; 288(23):16916-16925.
PMID: 23599429
PMC: 3675624.
DOI: 10.1074/jbc.M113.472100.
Pemphigus vulgaris autoantibody profiling by proteomic technique.
Kalantari-Dehaghi M, Anhalt G, Camilleri M, Chernyavsky A, Chun S, Felgner P
PLoS One. 2013; 8(3):e57587.
PMID: 23505434
PMC: 3591405.
DOI: 10.1371/journal.pone.0057587.
Pemphigus autoimmunity: hypotheses and realities.
Grando S
Autoimmunity. 2011; 45(1):7-35.
PMID: 21939410
PMC: 3251002.
DOI: 10.3109/08916934.2011.606444.
Cholinergic regulation of keratinocyte innate immunity and permeability barrier integrity: new perspectives in epidermal immunity and disease.
Curtis B, Radek K
J Invest Dermatol. 2011; 132(1):28-42.
PMID: 21918536
PMC: 4648359.
DOI: 10.1038/jid.2011.264.
Pathogenic relevance of IgG and IgM antibodies against desmoglein 3 in blister formation in pemphigus vulgaris.
Tsunoda K, Ota T, Saito M, Hata T, Shimizu A, Ishiko A
Am J Pathol. 2011; 179(2):795-806.
PMID: 21718682
PMC: 3157249.
DOI: 10.1016/j.ajpath.2011.04.015.
Relationship between target antigens and major histocompatibility complex (MHC) class II genes in producing two pathogenic antibodies simultaneously.
Zakka L, Keskin D, Reche P, Ahmed A
Clin Exp Immunol. 2010; 162(2):224-36.
PMID: 21069937
PMC: 2996589.
DOI: 10.1111/j.1365-2249.2010.04239.x.
Protective endogenous cyclic adenosine 5'-monophosphate signaling triggered by pemphigus autoantibodies.
Spindler V, Vielmuth F, Schmidt E, Rubenstein D, Waschke J
J Immunol. 2010; 185(11):6831-8.
PMID: 21037102
PMC: 3129745.
DOI: 10.4049/jimmunol.1002675.
Antimitochondrial autoantibodies in pemphigus vulgaris: a missing link in disease pathophysiology.
Marchenko S, Chernyavsky A, Arredondo J, Gindi V, Grando S
J Biol Chem. 2009; 285(6):3695-3704.
PMID: 20007702
PMC: 2823510.
DOI: 10.1074/jbc.M109.081570.
Myasthenia gravis and the tops and bottoms of AChRs: antigenic structure of the MIR and specific immunosuppression of EAMG using AChR cytoplasmic domains.
Lindstrom J, Luo J, Kuryatov A
Ann N Y Acad Sci. 2008; 1132:29-41.
PMID: 18567851
PMC: 2765226.
DOI: 10.1196/annals.1405.007.
Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans.
Wessler I, Kirkpatrick C
Br J Pharmacol. 2008; 154(8):1558-71.
PMID: 18500366
PMC: 2518461.
DOI: 10.1038/bjp.2008.185.
A perspective of pemphigus from bedside and laboratory-bench.
Kitajima Y, Aoyama Y
Clin Rev Allergy Immunol. 2007; 33(1-2):57-66.
PMID: 18094947
DOI: 10.1007/s12016-007-0036-5.
Novel mechanisms of target cell death and survival and of therapeutic action of IVIg in Pemphigus.
Arredondo J, Chernyavsky A, Karaouni A, Grando S
Am J Pathol. 2005; 167(6):1531-44.
PMID: 16314468
PMC: 1613205.
DOI: 10.1016/S0002-9440(10)61239-4.
Relevance of differential immunogenicity of human and mouse recombinant desmoglein-3 for the induction of acantholytic autoantibodies in mice.
Kaithamana S, Fan J, Memar O, Li K, Uitto J, Seetharamaiah G
Clin Exp Immunol. 2003; 132(1):16-23.
PMID: 12653831
PMC: 1808684.
DOI: 10.1046/j.1365-2249.2003.02135.x.